PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33403398-7	2021	Biochemical data showed that DMC inhibited tumor cells and osteoclasts by inhibiting the early activation of ERK and JNK MAPK pathway.	demethoxycurcumin	29-32	mitogen-activated protein kinase 8	Homo sapiens	117-120	
32710727-0	2020	Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.	demethoxycurcumin	0-17	mitogen-activated protein kinase 8	Homo sapiens	95-98	
32188144-5	2020	Moreover, p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK)1/2 were activated by DMC treatment in OSCC cells, and only the inhibition of p38 MAPK significantly abolished DMC-induced HO-1 expression and caspase-8/-9/-3 activation.	demethoxycurcumin	109-112	mitogen-activated protein kinase 8	Homo sapiens	58-88	
32188144-5	2020	Moreover, p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK)1/2 were activated by DMC treatment in OSCC cells, and only the inhibition of p38 MAPK significantly abolished DMC-induced HO-1 expression and caspase-8/-9/-3 activation.	demethoxycurcumin	198-201	mitogen-activated protein kinase 8	Homo sapiens	58-88